The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2016: Volume 21/ Issue 8 Article 4
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 21, Issue 8, 25 February 2016
Eurosurveillance editorial team: WHO recommendations on the composition of the 2016/17 influenza virus vaccines in the northern hemisphere

+ Author affiliations

Citation style for this article: Eurosurveillance editorial team. WHO recommendations on the composition of the 2016/17 influenza virus vaccines in the northern hemisphere. Euro Surveill. 2016;21(8):pii=30147. DOI:

On 25 February 2016, the World Health Organization (WHO) published recommendations on the composition of the trivalent and quadrivalent vaccines for the 2016/17 northern hemisphere influenza season [1]. The recommendations for the influenza A(H1N1)pdm09 strain remained the same as in the previous year while the recommended strains for influenza A(H3N2) and B viruses have changed from those recommended in 2015/16. WHO recommends that trivalent influenza vaccines should contain the following:

  • an A/California/7/2009 (H1N1)pdm09-like virus;

  • an A/Hong Kong/4801/2014 (H3N2)-like virus;

  • a B/Brisbane/60/2008-like virus.

For the quadrivalent influenza vaccines which contain two influenza B viruses, the WHO recommends that the above three viruses plus a B/Phuket/3073/2013-like virus be used.

As in previous years, national or regional authorities approve the composition and formulation of vaccines used in each country and are responsible for making recommendations regarding the use of the vaccine.

For more information, read here


  1. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. Geneva: WHO. Feb 2016. Available from:

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.